43 completed, 3 recruiting, 3 unknown, 2 terminated. 15 Phase 4, 14 Phase 3, 12 Phase 2, 5 Not applicable, 3 Phase 1.
Follow Raloxifene: new trials by email Literature Review of Raloxifene trials Research Report on Raloxifene
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain Memantine, Raloxifene - Brain Tumor | Phase 2 | Recruiting | The University of Texas Health Science Center at San Antonio | 108 | 2026-07-06 | 2026-09-22 |
| New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia raloxifene, Finasteride - BPH (Benign Prostatic Hyperplasia), Lower Urinary Track Symptoms | Phase 2 | Recruiting | Beth Israel Deaconess Medical Center | 242 | 2025-12-03 | 2026-03-23 |
| XCHT for Irinotecan-Induced Gut Toxicities (Randomized Controlled Trial) Xiao Chai Hu Tang (XCHT), Placebo, Irinotecan regimen - Xiao Chai Hu Tang, Irinotecan-induced Diarrhea | Not applicable | Recruiting | Guangzhou University of Traditional Chinese Medicine | 98 | 2024-03-08 | 2025-07-01 |
| XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study) Xiao Chai Hu Tang (XCHT), Raloxifene, FOLFIRI regimen - Malignant Tumor, Diarrhea | Not applicable | Completed | Guangzhou University of Traditional Chinese Medicine | 24 | 2021-07-16 | 2024-07-30 |
| Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients. Raloxifene, Placebo - SARS CoV 2 Infection | Phase 2 / Phase 3 | Completed | Dompé Farmaceutici S.p.A | 61 | 2021-01-22 | 2023-12-26 |
| Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data Raloxifene, Zoledronic Acid - Osteoporosis | Completed | Brigham and Women's Hospital | 18028 | 2020-09-22 | 2023-07-27 | |
| Comparative Antiresorptive Efficacy Discontinuation of Denosumab denosumab, alendronate, raloxifene - Osteoporosis, Postmenopausal, Osteoporosis | Phase 4 | Active not recruiting | Massachusetts General Hospital | 51 | 2018-11-30 | 2023-06-07 |
| DP-R213 Phase 1 Pharmacokinetics Study DP-R213, Raloxifene, Cholecaliferol - Healthy | Phase 1 | Completed | Alvogen Korea | 46 | 2017-01-03 | 2017-06-05 |
| Osteoporosis Treatment in Post-menopausal Women Raloxifene, Alendronate - Depressive Syndrome | Phase 4 | Unknown | Taichung Veterans General Hospital | 500 | 2017-01-01 | 2019-01-14 |
| Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder Raloxifene, Placebo - Schizophrenia, Schizoaffective Disorder | Phase 3 | Completed | Iris Sommer | 110 | 2016-08-01 | 2021-10-08 |
| DP-R213 Pharmacokinetics Study DP-R213, Raloxifene, Cholecaliferol - Healthy | Phase 1 | Completed | Alvogen Korea | 61 | 2016-05-01 | 2016-11-01 |
| A Drug-drug Interaction Study of DP-R213 Cholecalciferol, Raloxifene, Cholecalciferol and Raloxifene co-administration - Healthy | Phase 1 | Completed | Alvogen Korea | 24 | 2016-01-01 | 2016-03-11 |
| Efficacy Study of Raloxifene to Induce Ovulation in Polycystic Ovarian Syndrome Raloxifene, Clomiphene - Polycystic Ovarian Syndrome | Not applicable | Terminated | Bruce Lessey | 3 | 2012-06-01 | 2018-09-20 |
| Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men? Raloxifene Hydrochloride, Placebo - Schizophrenia, Schizoaffective Disorder | Phase 4 | Completed | The Alfred | 13 | 2012-01-01 | 2023-11-28 |
| The Effects of Seasonal Changes in Osteoporosis Treatment Raloxifene - Selective Estrogen Receptor Modulator (SERM) | Unknown | Toshihiko Kono | 200 | 2012-01-01 | 2016-11-30 | |
| Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU) Bazedoxifene, Bisphosphonate, Raloxifene - Osteoporosis, Postmenopausal | Completed | Pfizer | 10497 | 2011-07-25 | 2024-04-22 | |
| Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women Raloxifene, Lactosa (placebo arm) - Schizophrenia in Post Menopausal Women | Phase 3 | Completed | Fundació Sant Joan de Déu | 78 | 2011-07-01 | 2024-04-22 |
| Raloxifene in Treatment of Schizophrenia and Schizoaffective Disorder raloxifene, placebo - Schizophrenia, Schizoaffective Disorder | Phase 3 | Unknown | Sheba Medical Center | 200 | 2011-03-01 | 2011-01-20 |
| Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window? Teriparatide, Raloxifene - Osteoporosis | Phase 4 | Completed | University of Wisconsin, Madison | 26 | 2010-09-01 | 2014-09-22 |
| Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352) Alendronate, Etidronate, Ibandronate - Esophageal Cancer, Squamous Cell Carcinoma | Completed | Organon and Co | 684815 | 2010-02-26 | 2022-02-03 |
Showing 20 of 52. Sign in to see all of them.
Osteoporosis (10) · Osteoporosis, Postmenopausal (10) · Breast Neoplasms (6) · Schizophrenia (6) · Psychotic Disorders (4) · Mental Disorders (3) · Alzheimer Disease (2) · Neoplasms (2) · Polycystic Ovary Syndrome (2) · Adenocarcinoma (1) · Anovulation (1) · Bone Diseases, Metabolic (1) · Brain Neoplasms (1) · COVID-19 (1) · Carcinoma, Squamous Cell (1)
Eli Lilly and Company (8) · Alvogen Korea (3) · Fundació Sant Joan de Déu (2) · Guangzhou University of Traditional Chinese Medicine (2) · The Alfred (2) · University of Wisconsin, Madison (2) · Bayer (1) · Beth Israel Deaconess Medical Center (1) · Brigham and Women's Hospital (1) · Bruce Lessey (1) · Dompé Farmaceutici S.p.A (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Hospital de Clinicas de Porto Alegre (1) · Institute of Cancer Research, United Kingdom (1) · Iris Sommer (1)
United States (29) · Spain (6) · Australia (3) · Canada (3) · China (3) · Italy (3) · France (2) · Netherlands (2) · Taiwan (2) · Argentina (1) · Brazil (1) · Germany (1) · Israel (1) · Japan (1) · Mexico (1)
Alec Walker, MD, DrPH (1) · Andrew J Brenner, MD, PhD (1) · Anna Schwartz, FNP, PhD (1) · Anthony Howell, MD (1) · Antonio Cano, MD (1) · Aria Olumi, MD (1) · Bob Oranje, Ass. Prof. (1) · Bruce A Lessey, MD, PhD (1) · Bruce A. Lessey, MD, PhD (1)
PMID 14693739, PMID 16235377, PMID 16754727, PMID 16754728, PMID 16837676, PMID 18165396, PMID 18583470, PMID 18838053, PMID 19105706, PMID 19204301, PMID 19213563, PMID 19584192, PMID 19635615, PMID 20404000, PMID 21145540, PMID 21187295, PMID 21775836, PMID 21782166, PMID 21796066, PMID 21880792, PMID 21903021, PMID 22318751, PMID 23335675, PMID 23481531, PMID 24342775, PMID 26591005, PMID 27676118, PMID 28541645, PMID 31728631, PMID 33470755, PMID 34984851, PMID 35582123, PMID 36247744, PMID 39112628, PMID 39129266
2015 (1), R01AG018198 (1), R01AG029624 (1), R01DK142211 (1), R13AG020218 (1), ZIAMH002537-26 (1)